Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age
Importance Dexamethasone to prevent bronchopulmonary dysplasia in very preterm
neonates was associated with adverse neurodevelopmental events. Early low-dose …
neonates was associated with adverse neurodevelopmental events. Early low-dose …
Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age
O Baud, C Trousson, V Biran, E Leroy, D Mohamed… - 2017 - pubmed.ncbi.nlm.nih.gov
Importance Dexamethasone to prevent bronchopulmonary dysplasia in very preterm
neonates was associated with adverse neurodevelopmental events. Early low-dose …
neonates was associated with adverse neurodevelopmental events. Early low-dose …
[引用][C] Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age
O Baud, C Trousson, V Biran, E Leroy, D Mohamed… - JAMA, 2017 - cir.nii.ac.jp
Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm
Neonates and Neurodevelopmental Outcomes at 2 Years of Age | CiNii Research CiNii 国立 …
Neonates and Neurodevelopmental Outcomes at 2 Years of Age | CiNii Research CiNii 国立 …
Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
O Baud, C Trousson, V Biran, E Leroy, D Mohamed… - JAMA, 2017 - europepmc.org
Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm
Neonates and Neurodevelopmental Outcomes at 2 Years of Age. - Abstract - Europe PMC …
Neonates and Neurodevelopmental Outcomes at 2 Years of Age. - Abstract - Europe PMC …
[PDF][PDF] Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age
O Baud, C Trousson, V Biran, E Leroy - JAMA, 2017 - researchgate.net
OBJECTIVE To assess whether early hydrocortisone therapy in extremely preterm infants is
associated with neurodevelopmental impairment at 2 years of age. DESIGN, SETTING, AND …
associated with neurodevelopmental impairment at 2 years of age. DESIGN, SETTING, AND …
Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age
O Baud, C Trousson, V Biran - JAMA: the journal of the American …, 2017 - dialnet.unirioja.es
Importance Dexamethasone to prevent bronchopulmonary dysplasia in very preterm
neonates was associated with adverse neurodevelopmental events. Early low-dose …
neonates was associated with adverse neurodevelopmental events. Early low-dose …
Association Between Early Low‐Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age
O BAUD, C TROUSSON, V BIRAN, E LEROY - 2017 - cgmh.org.tw
Association Between Early Low‐Dose Hydrocortisone Therapy in Extremely Preterm Neonates
and Neurodevelopmental O Page 1 Association Between Early Low‐Dose Hydrocortisone …
and Neurodevelopmental O Page 1 Association Between Early Low‐Dose Hydrocortisone …